Andy Bader

Andy Bader

Company: Triumvira Immunologics

Job title: Chief Scientific Officer


Dr. Andreas Bader is Chief Scientific Officer at Triumvira Immunologics Inc. and has ~25 years’ experience in cancer research and oncology drug-discovery and development. Previously, Dr. Bader acted as Co-Founder and CEO of Orros Biotherapeutics LLC, and as a scientific Co-Founder of Mirna Therapeutics Inc., where he held multiple leading positions in R&D and led research programs from discovery to the completion of a Phase 1 clinical trial. Dr. Bader completed his post-doctoral training at The Scripps Research Institute, La Jolla, California, and received his PhD in Biochemistry and his MSc degree in Biology from the University of Innsbruck, Austria.

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.